Press ReleasesCellular Goods Announces Appointment Of New Chief Financial Officer

Cellular Goods Announces Appointment Of New Chief Financial Officer

-

CELLULAR Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce the appointment of Bruna Nikolla as Chief Financial Officer.

Ms Nikolla who will also serve as Company Secretary, will become a Director and is expected to join Cellular Goods with effect from 22 August 2022. Ms Nikolla will take over from Simon Walters who will continue with his role until 1 September 2022 to ensure an orderly handover.

Ms Nikolla is a member of the Chartered Institute of Management Accountants and brings more than 15 years of financial, strategic and commercial experience across multiple sectors including eCommerce, luxury retail, international technology, software and telecommunications.

She has significant leadership experience within the premium consumer goods sector and previously served as Finance Director of Trinny London, a premium beauty and skincare brand founded by UK television presenter and makeover guru Trinny Woodall. During her tenure at Trinny London, Bruna led the pricing and commercial strategy in a high-growth period. Between 2018 and 2020 she served as Finance Director at luxury eyewear brand Tom Davies Ltd. where she maintained overall responsibility for controlling all UK and head office finance as well as supporting the wider operations of the business.

Anna Chokina, Chief Executive of Cellular Goods, commented: “I would like to welcome Bruna, who brings a wealth of experience in the eCommerce and luxury goods sectors that will strengthen our commercial, financial and strategic capabilities. I look forward to working closely with Bruna to drive the Company’s growth and deliver long-term value for our shareholders.

“On behalf of the Board, I would also like to thank Simon for his support and valuable contribution over the course of Cellular’s listing journey and its move to commercial operations. We wish him well in his future endeavours.”

Latest news

Tetra Pharm Technologies Secures €9 Million In Series A Round To Expand R&D Operations

PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a...

European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues

Oxford Cannabinoid Technologies  THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the...

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.  On Tuesday,...

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK And EU Market Position

PRESS RELEASE 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...

Czechia Could Be A ‘Step Towards Convincing The Rest Of Europe To Create A Legal Cannabis Framework’

EARLIER this week, Czechia’s national anti-drug coordinator Jindřich Vobořil, described as the ‘locomotive’ driving rapid cannabis reform in the...

Hellenic Dynamics ‘On Track’ To Supply Flowers To Germany By Mid 2023

PRESS RELEASE Hellenic Dynamics' core strategy is to develop and operate its 40,000 square metre active THC cultivation licence from...

Must read

You might also likeRELATED
Recommended to you